SCHEMBL8099449

SCHEMBL8099449

CCOC(=O)CNC(=O)Oc1ncc(C(=O)NS(=O)(=O)c2ccc(C(=O)N(CC)CC)cc2)cc1OCC(C)C

nearest known ligand 0.37

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.37
HPGD P15428 1/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
SCN9A Q15858 7/20 0.36
SCN5A Q14524 5/20 0.36
PTGS2 P35354 1/20 0.35
EGFR P00533 2/20 0.34
NAMPT P43490 1/20 0.34
MYC P01106 1/20 0.34
MAX P61244 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8767144 0.91 LMNA (0.38) LMNAHPGDHTTSMN1; SMN2SCN9A
SCHEMBL8096944 0.91 SMN1; SMN2 (0.39) LMNAHPGDHTTSMN1; SMN2SCN9A
SCHEMBL8875047 0.88 SMN1; SMN2 (0.36) LMNAHPGDHTTSMN1; SMN2SCN9A
SCHEMBL8106135 0.87 LMNA (0.40) LMNAHPGDHTTSMN1; SMN2PTGS2
SCHEMBL8767110 0.85 LMNA (0.40) LMNAHTTSMN1; SMN2
SCHEMBL8099328 0.84 P4HTM (0.37) SMN1; SMN2SCN9APTGS2EGFR
SCHEMBL8097664 0.82 ABL1 (0.37) LMNAHPGDHTTSMN1; SMN2SCN9A
SCHEMBL8767162 0.81 LMNA (0.40) LMNAHPGDHTTSMN1; SMN2SCN9A
SCHEMBL8875475 0.80 P4HTM (0.39) LMNAHPGDHTTSMN1; SMN2PTGS2
SCHEMBL8097619 0.80 ALDH1A1 (0.41) LMNAHTTSMN1; SMN2SCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0673932-B1 Sulfonamidocarbonyl-pyridine-2-carboxamides as well as their pyridine-N-oxides, process for their preparation and their use as medicaments HOECHST AG (DE) 2000-06-07 EP disclosed
EP-0673932-A1 Sulfonamidocarbonyl-pyridine-2-carboxamides as well as their pyridine-N-oxides, process for their preparation and their use as medicaments HOECHST AKTIENGESELLSCHAFT (DE) 1995-09-27 EP disclosed